Conivaptan HCl
≥99%
- Product Code: 73750
CAS:
168626-94-6
| Molecular Weight: | 535.04 g./mol | Molecular Formula: | C₃₂H₂₇ClN₄O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD00945712 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C |
Product Description:
Conivaptan HCl is primarily used in the management of hyponatremia, a condition characterized by low sodium levels in the blood. It is particularly effective in treating euvolemic hyponatremia, which occurs when there is a normal fluid volume in the body but an imbalance in sodium concentration. The drug works by acting as a dual vasopressin receptor antagonist, inhibiting the action of vasopressin on V1A and V2 receptors in the kidneys. This inhibition reduces water reabsorption in the renal tubules, leading to increased free water excretion and a gradual correction of sodium levels. It is administered intravenously in a hospital setting, allowing for careful monitoring of electrolyte balance and fluid status. Conivaptan HCl is especially valuable in cases where rapid correction of hyponatremia is necessary to prevent neurological complications. However, its use requires caution to avoid overly rapid sodium correction, which can lead to osmotic demyelination syndrome.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.010 | 10-20 days | $143.52 |
+
-
|
| 0.050 | 10-20 days | $469.07 |
+
-
|
Conivaptan HCl
Conivaptan HCl is primarily used in the management of hyponatremia, a condition characterized by low sodium levels in the blood. It is particularly effective in treating euvolemic hyponatremia, which occurs when there is a normal fluid volume in the body but an imbalance in sodium concentration. The drug works by acting as a dual vasopressin receptor antagonist, inhibiting the action of vasopressin on V1A and V2 receptors in the kidneys. This inhibition reduces water reabsorption in the renal tubules, leading to increased free water excretion and a gradual correction of sodium levels. It is administered intravenously in a hospital setting, allowing for careful monitoring of electrolyte balance and fluid status. Conivaptan HCl is especially valuable in cases where rapid correction of hyponatremia is necessary to prevent neurological complications. However, its use requires caution to avoid overly rapid sodium correction, which can lead to osmotic demyelination syndrome.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :